Kayne Anderson Rudnick Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-75
Closed -$6K 679
2022
Q1
$6K Buy
+75
New +$6K ﹤0.01% 559
2021
Q1
Sell
-6
Closed -$1K 710
2020
Q4
$1K Buy
+6
New +$1K ﹤0.01% 662